TransOral Robotic Surgery (TORS) is the world's first group of minimally invasive robotic surgery techniques that enable Penn surgeons to remove benign and malignant tumors of the mouth and throat.
Bert W. O'Malley, Jr., MD, and Gregory S. Weinstein, MD, developed and perfected TORS. They have performed more TORS procedures than any other physicians in the world.
Today, TORS at Penn Medicine is a world-class surgical program comprised of leading surgeons, anesthesiologists, nurses, and clinicians dedicated to providing superior patient outcomes through the use of robotic-assisted technology. The program benefits patients seeking state-of-the-art care, but also educates physicians who come from around the world to observe and learn about this groundbreaking procedure.
Along with performing all of the original research, Penn Medicine was the first medical center in the world to offer TORS in 2005.
TORS is an exceptional example of how Penn surgeons have taken a clinical breakthrough from "bench to bedside," providing patients with the best possible care.
In This Section
TransOral Robotic Surgery (TORS) is a leading-edge surgical program comprised of expert physicians who perform minimally invasive robotic surgery techniques that provide superior outcomes.
TransOral Robotic Surgery (TORS) is a minimally invasive, robotic surgery technique that removes benign and malignant tumors of the mouth and throat.
Penn Medicine physicians are experts in performing TransOral Robotic Surgery (TORS), a minimally invasive robotic surgery technique that treats benign and malignant tumors of the head and neck.
Penn Medicine conducts research and clinical trials using TORS to treat individuals with head and neck cancer that have shown to dramatically improve quality of life.